title: Protective Effects of Ginger against Aspirin-Induced Gastric Ulcers in Rats.
abstract: We investigated the mechanism underlying the protective effects of ginger against gastric damage induced by aspirin in rats. Gastric mucosal lesions were produced by orally administering 200 mg/kg aspirin suspended in 1% carboxymethylcellulose solution to pyloric-ligated male Wistar rats. Ginger powder (200 mg/kg) markedly reduced the aspirin-induced gastric hemorrhagic ulcer area. The total acidity of gastric juice was not significantly influenced by aspirin or ginger. Ginger powder did not affect the aspirin-induced reduction in mucosal prostaglandin E2 (PGE2) content; however, it did ameliorate the aspirin-induced increases in mucosal activity of the inducible form of NO synthase (iNOS) and plasma tumor necrosis factor (TNF)-α and interleukin (IL)-1β levels. In the next experiment, high and low doses of 6-gingerol and 6-shogaol were used instead of ginger powder in the same experimental model to examine their roles in the anti-ulcer mechanism of ginger. Both 6-gingerol and 6-shogaol reduced aspirin induced ulcer formation, mucosal iNOS and plasma TNF-α and IL-1β levels. In conclusion, ginger powder prevents the aspirin induced gastric ulcer formation by reducing mucosal iNOS activity and the plasma levels of inflammatory cytokines but does not affect gastric juice or acid production or mucosal PGE2 content. This protective effect of ginger powder against gastric ulcers may be attributable to both gingerol and shogaol.
authors.affiliation: Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8503, Japan.
authors.forename: Zhongzhi
authors.initials: Z
authors.lastname: Wang
authors.forename: Junichi
authors.initials: J
authors.lastname: Hasegawa
authors.forename: Xinhui
authors.initials: X
authors.lastname: Wang
authors.forename: Akiko
authors.initials: A
authors.lastname: Matsuda
authors.forename: Takahiro
authors.initials: T
authors.lastname: Tokuda
authors.forename: Norimasa
authors.initials: N
authors.lastname: Miura
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Watanabe
keywords: aspirin; gastric damage; ginger powder; inducible form of NO synthase activity; inflammatory cytokine
references.citation: J Ethnopharmacol. 2005 Jan 4;96(1-2):207-10
references.pmid: 15588672
references.citation: Am J Physiol. 1999 Jun;276(6):G1313-6
references.pmid: 10362633
references.citation: Br J Pharmacol. 2007 Apr;150(7):913-9
references.pmid: 17325651
references.citation: Gastroenterology. 1995 Feb;108(2):393-401
references.pmid: 7530670
references.citation: Biochem Biophys Res Commun. 2008 Aug 29;373(3):429-34
references.pmid: 18577375
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Sep 1;856(1-2):41-7
references.pmid: 17561453
references.citation: Gastroenterol Clin North Am. 1992 Sep;21(3):631-41
references.pmid: 1516961
references.citation: Mol Nutr Food Res. 2008 Dec;52(12):1467-77
references.pmid: 18683823
references.citation: Am J Physiol. 1990 Sep;259(3 Pt 1):G462-7
references.pmid: 2169206
references.citation: Gut. 2004 Jun;53(6):791-6
references.pmid: 15138204
references.citation: Am J Chin Med. 1989;17(1-2):51-6
references.pmid: 2589236
references.citation: J Physiol Pharmacol. 2005 Sep;56 Suppl 5:33-55
references.pmid: 16247188
references.citation: Am J Physiol. 1996 Jan;270(1 Pt 1):G42-8
references.pmid: 8772499
references.citation: Physiol Rev. 2008 Oct;88(4):1547-65
references.pmid: 18923189
references.citation: Microsc Res Tech. 2001 Jun 1;53(5):325-35
references.pmid: 11376493
references.citation: Scand J Gastroenterol. 1999 Feb;34(2):129-34
references.pmid: 10192188
references.citation: Fundam Clin Pharmacol. 2003 Jun;17(3):301-13
references.pmid: 12803569
references.citation: Gastroenterology. 2008 Jul;135(1):41-60
references.pmid: 18549814
references.citation: Phytomedicine. 2007 Feb;14(2-3):123-8
references.pmid: 16709450
references.citation: Indian J Med Res. 2006 Jun;123(6):799-806
references.pmid: 16885602
references.citation: Circ Res. 2000 Feb 4;86(2):205-13
references.pmid: 10666417
references.citation: Gastroenterology. 2000 Aug;119(2):512-20
references.pmid: 10930387
references.citation: Arthritis Rheum. 2001 Nov;44(11):2531-8
references.pmid: 11710709
references.citation: World J Gastroenterol. 2006 Jan 28;12(4):568-73
references.pmid: 16489670
references.citation: Cell Physiol Biochem. 2007;20(1-4):205-12
references.pmid: 17595529
references.citation: J Physiol Pharmacol. 2002 Mar;53(1):39-50
references.pmid: 11939718
references.citation: Gut. 1993 Feb;34(2):156-60
references.pmid: 8381759
references.citation: Dig Dis Sci. 2001 Apr;46(4):845-51
references.pmid: 11330422
references.citation: Am J Physiol. 1992 Dec;263(6 Pt 1):G920-6
references.pmid: 1476199
references.citation: J Ethnopharmacol. 1988 Jul-Aug;23(2-3):299-304
references.pmid: 3193792
references.citation: Indian J Pharm Sci. 2009 Sep;71(5):554-8
references.pmid: 20502577
references.citation: Food Chem Toxicol. 2002 Aug;40(8):1091-7
references.pmid: 12067569
references.citation: Toxicology. 2004 Nov 15;204(2-3):203-8
references.pmid: 15388246
references.citation: J Pharmacol Toxicol Methods. 2004 Mar-Apr;49(2):89-95
references.pmid: 14990333
references.citation: Chem Biol Interact. 2006 Jul 10;161(3):262-70
references.pmid: 16797507
references.citation: Oncogene. 2005 Apr 7;24(15):2558-67
references.pmid: 15735738
references.citation: Am J Physiol. 1986 Jun;250(6 Pt 1):G842-9
references.pmid: 3459368
references.citation: J Physiol Pharmacol. 2006 Nov;57 Suppl 5:125-36
references.pmid: 17218764